Head-to-head comparisons of medication uses, side effects, warnings, and more.
Eliquis (apixaban) and Xarelto (rivaroxaban) are both direct-acting oral anticoagulants (DOACs) used to prevent and treat blood clots. Both medications are effective in reducing the risk of stroke and treating conditions caused by blood clots, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). Xarelto is also FDA approved for other heart-related conditions, such as coronary artery disease and, when combined with aspirin, peripheral artery disease. Eliquis is typically taken twice daily and might have a lower risk of bleeding compared to Xarelto, which is often taken once daily. Neither medication requires frequent blood tests or that you follow dietary restrictions like the traditional blood thinner warfarin (Jantoven) does. Eliquis may be preferable for patients with kidney problems. Common side effects for both medications include bleeding and bruising. Serious risks include life-threatening bleeding.
See more from our pharmacists
Eliquis (apixaban) is a direct-acting oral anticoagulant (DOAC) that's used to prevent and treat certain types of blood clots. Eliquis (apixaban) is taken by mouth, typically twice daily. While generic versions of this medication have been approved by the FDA, they might not hit the market until 2026.
Xarelto (rivaroxaban) is a blood thinner that's used to treat and prevent blood clots, like stroke or deep vein thrombosis (DVT), in people with certain heart and blood vessel conditions. Depending on the reason you're using the medication for, you'll take a dose either once or twice a day. The most common side effect is bleeding, which in some cases can become serious and life-threatening. Currently, there is no generic version since it's only available as a brand-name medication.
Adults:
Children:
Adults
Children
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.